I tumori cutanei maligni di interesse ORL - Luigi D'Ottavi - AOOI

Bapat B, Xia L, Madlensky L, Mitri A, Tonin P, Narod SA, Gallinger S: The genetic basis
of Muir-Torre syndrome includes the hMLH1 locus. Am J Hum Genet. 1996,
Sep; 9(3): 36-9.
Halata Z, Grim M, Bauman KI:Friedrich Sigmund Merkel and his “Merkel cell”, morphology,
development, and physiology: review and new results. Anat Rec A Discov Mol
Cell Evol Biol. 2003, Mar;2 1(1):22 -39.
Toker C: Trabecular carcinoma of the skin. Arch Dermatol 19 2; 10 : 10 -110.
Boyle F, Pendlebury S, Bell D: Further insights into the natural history and management
of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Int J Radiat Oncol Biol
Phys. 199 , Jan 1 ;31(2):31 -23.
Miller RW, Rabkin CS: Merkel cell carcinoma and melanoma: etiological similarities and
differences. Cancer Epidemiol Biomarkers Prev. 1999, Feb; (2):1 3- .
Lunder EJ, Stern RS: Merkel-cell carcinomas in patients treated with methoxsalen and
ultraviolet A radiation. N Engl J Med. 199 , Oct 22;339(1 ):124 - .
Pectasides D, Pectasides M, Economopoulos T: Merkel cell cancer of the skin. Ann Oncol.
2006, Oct;1 (10):14 9-9 .
Van Gele M, Van Roy N, Ronan SG, Messiaen L, Vandesompele J, Geerts ML, Naeyaert
JM, Blennow E, Bar-Am I, Das Gupta TK, van der Drift P, Versteeg R, Leonard JH,
Speleman F: Molecular analysis of 1p36 breakpoints in two Merkel cell carcinomas.
Genes Chromosomes Cancer 199 , Sep;23(1):6 - 1.
Leonard JH, Williams G, Walters MK, Nancarrow DJ, Rabbitts PH: Deletion mapping of
the short arm of chromosome 3 in Merkel cell carcinoma. Genes Chromos Cancer
1996, Feb;1 (2):102- .
Van Gele M, Kaghad M, Leonard JH, Van Roy N, Naeyaert JM, Geerts ML, Van Belle S,
Cocquyt V, Bridge J, Sciot R, De Wolf-Peeters C, De Paepe A, Caput D, Speleman
F: Mutation analysis of P 3 and TP 3 in Merkel cell carcinoma. Br J Cancer. 2000,
Feb; 2(4): 23-6.
Leonard JH, Cook AL, Van Gele M, Boyle GM, Inglis KJ, Speleman F, Sturm RA:Proneural
and proneuroendocrine transcription factor expression in cutaneous mechanoreceptor
(Merkel) cells and Merkel cell carcinoma. Int J Cancer. 2002, Sep 10;101(2):103-10.
Poulsen M: Merkel-cell carcinoma of the skin. Lancet Oncol. 2004, Oct; (10): 93-9.
Schwartz BK, Peraza JE: Pilomatricomas associated with myotonic dystrophy. J Am Acad
Dermatol. 19 , Apr;16(4): - .
Masuno M, Imaizumi K, Ishii T, Kuroki Y, Baba N, Tanaka Y: Pilomatrixomas in Rubinstein-
Taybi syndrome. Am J Med Genet. 199 , Apr 2 ; (1): 1-2.
Chan EF, Gat U, McNiff JM, Fuchs E: A common human skin tumour is caused by activating
mutations in beta-catenin. Nat Genet. 1999, Apr;21(4):410-3.
Rubinfeld B, Souza B, Albert I, Müller O, Chamberlain SH, Masiarz FR, Munemitsu S,
Polakis P: Association of the APC gene product with beta-catenin. Science 1993,
Dec 10;262( 140):1 31-4.
Pujol RM, Casanova JM, Egido R, Pujol J, de Moragas JM: Multiple familial pilomatricomas:
a cutaneous marker for Gardner syndrome? Pediatr Dermatol. 199 ,
Dec;12(4):331- .
Young AL; Kellermayer R; Szigetin R; Teszas A; Azmi S; Celebi JT: CYLD mutations
underlie Brooke-Spiegler, familial cylindromatosis, and multiple familial trichoepithelioma
syndromes. Clin. Genet. 2006, 0: 246-249.
Saggar S, Chernoff KA, Lodha S, Horev L, Kohl S, Honjo RS, Brandt HR, Hartmann K,
Celebi JT: CYLD mutations in familial skin appendage tumours. J Med Genet. 200 ,
May;4 ( ):29 -302.
99